Home › Funds › Quinn Opportunity Partners LLC › BNTX
Quinn Opportunity Partners LLC position in BNTX
BIONTECH SE · Health Care
Quinn Opportunity Partners LLC reported holding 153,832 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$14.3M, representing 0.67% of its reported portfolio and ranking #35 among its reported holdings. Quinn Opportunity Partners LLC has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Quinn Opportunity Partners LLC's BNTX position evolved
Quinn Opportunity Partners LLC first disclosed a stake in BNTX in Q3 2023 at 704,383 shares (US$76.5M). Across 12 filings, Quinn Opportunity Partners LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 153,832 shares valued at US$14.3M — a reduction of -75,000 shares quarter over quarter.. Notable position changes include a 87% trim in Q2 2025 (shares fell 7% over the following quarter), a 146% increase in Q4 2025 (shares fell 7% over the following quarter), a 305% increase in Q1 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 704.38K | $76.52M | New |
| Q4 2023 | 719.58K | $75.94M | Add |
| Q1 2024 | 758.38K | $69.96M | Add |
| Q2 2024 | 683.29K | $54.91M | Reduce |
| Q3 2024 | 404.50K | $48.04M | Reduce |
| Q4 2024 | 356.19K | $40.59M | Reduce |
| Q1 2025 | 197.95K | $18.02M | Reduce |
| Q2 2025 | 25.07K | $2.67M | Reduce |
| Q3 2025 | 23.00K | $2.27M | Reduce |
| Q4 2025 | 56.50K | $5.38M | Add |
| Q1 2026 | 228.83K | $20.34M | Add |
| Q2 2026 | 153.83K | $14.31M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 35 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M sh · $140.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on Quinn Opportunity Partners LLC
FAQ
How long has Quinn Opportunity Partners LLC held BNTX?
Quinn Opportunity Partners LLC has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Quinn Opportunity Partners LLC's current position in BNTX?
As of Q2 2026, Quinn Opportunity Partners LLC holds 153.83K shares of BNTX (BIONTECH SE), valued at $14.31M, representing 0.67% of its reported portfolio and ranking #35.
Has Quinn Opportunity Partners LLC been buying or selling BNTX?
In the latest 13F filing (Q2 2026), Quinn Opportunity Partners LLC reduced its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.